Hem › Myelofibros › Washington › Seattle
Kliniska studier för Myelofibros i Seattle, WA
11 studier för Myelofibros söker deltagare vid platser i och runt Seattle (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RekryterarFas 1/2
- University of Washington - Fred Hutchinson Cancer Center, Seattle
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
RekryterarFas 3
- Fred Hutch Cancer Research, Seattle
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RekryterarFas 3
- University of Washington, Seattle
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekryterarFas 1/2
- University of Washington, Seattle
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
RekryterarFas 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
RekryterarFas 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
RekryterarFas 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
RekryterarFas 2
- GSK Investigational Site, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekryterarFas 2
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Seattle
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
RekryterarFas 3
- Fred Hutchinson Cancer Centre, Seattle
Myelofibros-studier i andra städer
- Houston, TX19 studier
- New York City, NY18 studier
- Boston, MA12 studier
- Durham, NC12 studier
- Columbus, OH11 studier
- Salt Lake City, UT10 studier
- Miami, FL10 studier
- Nashville, TN9 studier
- Cleveland, OH9 studier
- Tampa, FL9 studier
- Atlanta, GA9 studier
- Baldwin Park, CA9 studier
Andra studier i Seattle
- Icke-småcellig lungcancer53 studier
- Cancer (alla typer)49 studier
- Prostatacancer42 studier
- Akut myeloid leukemi40 studier
- Bröstcancer39 studier
- Metastaserande cancer39 studier
- Kolorektal cancer34 studier
- Lungcancer33 studier
- Äggstockscancer30 studier
- Multipelt myelom22 studier
- Myelodysplastiska syndrom21 studier
- Akut lymfoblastisk leukemi21 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.